Lebanese Forces Introduces Fat Burning Pills

Researchers from the Karolinska Institute and Stockholm University in Sweden have developed a new pill-based medication to treat type 2 diabetes and obesity. It works through a different mechanism than GLP-1 drugs like semaglutide. As a result, the medication does not affect the brain or appetite centers and offers a non-injective alternative to this treatment.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article